cancer-related fatigue,CRF
Conditions
Interventions
Control group:Based on the patient's current condition, symptomatic treatments such as nutritional support, pain relief, and antiemetic therapy were administered.
Xiaosheng Liu Decoction group:On the basis of the control group, the patients were treated with oral administration of Xiaosheng Liu Decoction. One dose was prescribed per day, decocted in water to 30
Acupoint Application group:On the basis of the control group, acupoint application was administered. Dangshen (Codonopsis Radix), Maidong (Ophiopogon japonicus), and Wuweizi (Schisandra chinensis) wer
Combination group:On the basis of the control group, the patients were treated with combined therapy consisting of oral Xiaosheng Liu Decoction and acupoint application.
Sponsors
People's Hospital of Boluo County, Huizhou, 516100, China
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Age 18–80 years; (2) Meet the diagnostic criteria for malignant tumor and cancer-related fatigue (CRF); (3) Meet the diagnostic criteria for Qi and Yin Deficiency Pattern; (4) Karnofsky Performance Status (KPS) score = 60, with life expectancy > 3 months; (5) Voluntarily participate in the study and sign the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Fatigue resulting from excessive exertion that can be relieved by short-term rest; (2) Presence of severe hematologic diseases, or cardiac, hepatic, or renal diseases or complications; (3) Allergy to acupoint application or any component of the oral Chinese herbal formula; (4) Mental or cognitive disorders that may hinder cooperation with treatment; (5) Participation in other drug clinical trials concurrently; (6) Other reasons deemed unsuitable for participation in the clinical trial by the investigators.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fatigue severity;Traditional Chinese Medicine (TCM) syndrome score and its therapeutic efficacy; | — |
Secondary
| Measure | Time frame |
|---|---|
| European Organnization for Research and Treatment of Life Questionnaire-core 30,EORTC OLQ-30; | — |
Countries
China
Contacts
Public ContactFei Li
People's Hospital of Boluo County, Huizhou, 516100, China
Outcome results
None listed